Page last updated: 2024-11-06

pentadecan-2-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID61303
CHEMBL ID3273567
CHEBI ID89254
SCHEMBL ID336157
MeSH IDM0059518

Synonyms (34)

Synonym
methyl tridecyl ketone
2-pentadecanone
2-pentadecanone, >=98%, fg
pentadecan-2-one
2-pentadecanone, >=98.5%
SSV ,
2345-28-0
AKOS009157795
LMFA12000056
einecs 219-064-8
b2q48j997n ,
fema no. 3724
ai3-11706
unii-b2q48j997n
FT-0613261
2-pentadecanone [fhfi]
chebi:89254 ,
CHEMBL3273567
SCHEMBL336157
DTXSID6062333
pentadecanone
2-pentadecanone, analytical standard
mfcd00053712
J-015112
2-pentandecanone
fema 3724
Q27161440
A878236
pentadecanone; 95%; methyl n-tridecyl ketone
D92066
AS-56748
CS-0187603
CAA34528
SY049907
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ketoneA compound in which a carbonyl group is bonded to two carbon atoms: R2C=O (neither R may be H).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
methyl ketone biosynthesis (engineered)018

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1144507Hypocholesterolemic activity in Sprague-Dawley rat assessed as serum cholesterol level at 10 mg/kg/day, po administered via intubation measured on day 4 by Liebermann-Burchard method relative to control1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Cycloalkanones. 8. Hypocholesterolemic activity of long-chain ketones related to pentadecanone.
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
AID1144508Hypocholesterolemic activity in Sprague-Dawley rat assessed as serum cholesterol level at 10 mg/kg/day, po administered via intubation measured on day 10 by Liebermann-Burchard method relative to control1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Cycloalkanones. 8. Hypocholesterolemic activity of long-chain ketones related to pentadecanone.
AID1144510Toxicity in Sprague-Dawley rat assessed as increase in body weight at 10 mg/kg/day measured on day 10 (Rvb = 160 +/- 13%)1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Cycloalkanones. 8. Hypocholesterolemic activity of long-chain ketones related to pentadecanone.
AID1144509Hypocholesterolemic activity in Sprague-Dawley rat assessed as serum cholesterol level at 10 mg/kg/day, po administered via intubation measured on day 16 by Liebermann-Burchard method relative to control1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Cycloalkanones. 8. Hypocholesterolemic activity of long-chain ketones related to pentadecanone.
AID1144511Toxicity in Sprague-Dawley rat assessed as increase in body weight at 10 mg/kg/day measured on day 16 (Rvb = 195 +/- 16%)1976Journal of medicinal chemistry, Feb, Volume: 19, Issue:2
Cycloalkanones. 8. Hypocholesterolemic activity of long-chain ketones related to pentadecanone.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (80.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.53 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]